SPAG1 Gene Primary Ciliary Dyskinesia Type 28 Genetic Test sale cost 4400 AED
TRMU Gene Mitochondrial Modifier of Deafness Genetic Test sale cost 4400 AED TRMU Gene Mitochondrial Modifier of Deafness Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
CISD2 Gene Wolfram Syndrome Type 2 Genetic Test sale cost 4400 AED CISD2 Gene Wolfram Syndrome Type 2 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

SPAG1 Gene Primary Ciliary Dyskinesia Type 28 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SPAG1 Gene Primary Ciliary Dyskinesia Type 28 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE. Priced at 4400 AED, this test specifically targets the SPAG1 gene, mutations in which are known to cause Primary Ciliary Dyskinesia (PCD) Type 28. PCD is a rare genetic disorder characterized by chronic respiratory tract infections, abnormal organ positioning, and fertility issues, resulting from defective cilia function. The SPAG1 gene plays a crucial role in the proper formation and function of cilia, and its mutations can lead to the symptoms associated with PCD.

The test is conducted using a sample of the patient’s DNA, obtained through a non-invasive method such as a blood draw or a cheek swab. It is designed to detect specific genetic mutations in the SPAG1 gene, providing a definitive diagnosis of PCD Type 28. This information is crucial for guiding treatment decisions, managing symptoms, and offering genetic counseling to affected families.

DNA Labs UAE, a leading provider of genetic testing services in the region, ensures that the test is conducted with the highest standards of accuracy and confidentiality. The test is recommended for individuals exhibiting symptoms of PCD or those with a family history of the condition, aiming to offer them a clear understanding of their genetic status and how it might impact their health and lifestyle.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SPAG1 Gene Primary ciliary dyskinesia type 28 Genetic Test

At DNA Labs UAE, we offer the SPAG1 Gene Primary ciliary dyskinesia type 28 Genetic Test at a cost of AED 4400.0.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Ear Nose Throat Disorders
  • Doctor: ENT Doctor
  • Test Department: Genetics
  • Pre Test Information: Clinical History of Patient who is going for SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test gene SLC52A20

Test Details

The SPAG1 gene is associated with primary ciliary dyskinesia type 28. Primary ciliary dyskinesia (PCD) is a genetic disorder that affects the structure and function of cilia, which are microscopic hair-like structures found on the surface of cells. PCD can cause a variety of symptoms, including chronic respiratory infections, sinusitis, bronchiectasis, and infertility.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes. In the case of primary ciliary dyskinesia, NGS genetic testing can be used to identify mutations in the SPAG1 gene that may be responsible for the disorder. By analyzing the DNA sequence of the SPAG1 gene, NGS genetic testing can detect any genetic variations or mutations that may be present. This information can help diagnose primary ciliary dyskinesia type 28 and provide valuable insights into the underlying cause of the disorder.

NGS genetic testing for primary ciliary dyskinesia can be performed using a blood sample or other DNA-containing samples. The test is usually ordered by a healthcare provider who suspects that a person may have primary ciliary dyskinesia based on their symptoms and clinical findings. It is important to note that genetic testing for primary ciliary dyskinesia is not always necessary for diagnosis. Other diagnostic tests, such as nasal nitric oxide measurement, ciliary function testing, and electron microscopy of cilia, may also be used to confirm the diagnosis.

If you or someone you know is suspected to have primary ciliary dyskinesia type 28, it is recommended to consult with a healthcare professional or a genetic counselor who can provide further information and guidance regarding genetic testing options.

Test Name SPAG1 Gene Primary ciliary dyskinesia type 28 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test gene SLC52A20
Test Details

The SPAG1 gene is associated with primary ciliary dyskinesia type 28. Primary ciliary dyskinesia (PCD) is a genetic disorder that affects the structure and function of cilia, which are microscopic hair-like structures found on the surface of cells. PCD can cause a variety of symptoms, including chronic respiratory infections, sinusitis, bronchiectasis, and infertility.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes. In the case of primary ciliary dyskinesia, NGS genetic testing can be used to identify mutations in the SPAG1 gene that may be responsible for the disorder.

By analyzing the DNA sequence of the SPAG1 gene, NGS genetic testing can detect any genetic variations or mutations that may be present. This information can help diagnose primary ciliary dyskinesia type 28 and provide valuable insights into the underlying cause of the disorder.

NGS genetic testing for primary ciliary dyskinesia can be performed using a blood sample or other DNA-containing samples. The test is usually ordered by a healthcare provider who suspects that a person may have primary ciliary dyskinesia based on their symptoms and clinical findings.

It is important to note that genetic testing for primary ciliary dyskinesia is not always necessary for diagnosis. Other diagnostic tests, such as nasal nitric oxide measurement, ciliary function testing, and electron microscopy of cilia, may also be used to confirm the diagnosis.

If you or someone you know is suspected to have primary ciliary dyskinesia type 28, it is recommended to consult with a healthcare professional or a genetic counselor who can provide further information and guidance regarding genetic testing options.

SKU: TEST-2784 Category:

Related products